CN101161279A - A Chinese medicine for treating gland hyperplasia and galactophore disease - Google Patents

Abstract

A traditional Chinese medicine for diminishing coagula of galactophore and its containing characteristic components are disclosed in the present invention. Radix bupleuri is 1 to 25 percent, scutellaria is 1 to 25 percent, cyperus rotundus is 1 to 50 percent, official magnolia is 1 to 50 percent, dried orange peel is 1 to 25 percent, pinellia is 1 to 25 percent, prunella spike 1 to 60 percent, sparganium stoloniferum is 1 to 50 percent, zedoary turmeric is 1 to 50 percent, myrrh is 1 to 25 percent, curcuma is 1 to 25 percent, rhizome corydalis is 1 to 25 percent, sown grass 1 to 20 percent, safflower is 1 to 20 percent, pericarpium citri reticulatae viride is 1 to 25 percent, white peony root 1 to 25 percent. The total weight of above medicines is 100 percent.

Description

A kind of Chinese medicine for the treatment of cyclomastopathy and mastopathy

One, technical field

The present invention is a kind of oral Chinese medicine of easy treatment mastopathy.

Two, technical background

Mastopathy is a kind of commonly encountered diseases, is mainly in youth and the middle-aged women 30-50 sickness rate between year up to 85-95%.To this disease, still there is not specific drug at present, though the medicine of treatment mastopathy is arranged in known product or document record, they can only play invigorating blood circulation blood stasis dispelling, the effect of relief of symptoms from can not get treatment in essence, can not reach the purpose of radical cure.

Three, summary of the invention

The purpose of this invention is to provide a kind of mammary gland eliminating stagnation Chinese medicine, should be able to short treating period in mastopathy such as treatment cyclomastopathy etc., instant effect can take orally and can external application, and it is main effecting a permanent cure, and should be able to reach radical cure.

Another object of the present invention provides a kind of mammary gland eliminating stagnation Chinese medicine, should be able to be easy to industrialized exploitation, produces the mammary gland eliminating stagnation Chinese medicine of multiple dosage form.

The objective of the invention is to adopt following technical proposal to realize.

Radix Bupleuri 1-25% Radix Scutellariae 1-25% Rhizoma Cyperi 1-50% Cortex Magnoliae Officinalis 1-50%

Pericarpium Citri Reticulatae 1-25% Rhizoma Pinelliae 1-25% Spica Prunellae 1-60% rhizoma sparganic 1-50%

Rhizoma Curcumae 1-50% Myrrha 1-25% Radix Curcumae 1-25% Rhizoma Corydalis 1-25%

SHENGCAO 1-20% Flos Carthami 1-20% Pericarpium Citri Reticulatae Viride 1-25% Radix Paeoniae Alba 1-25%

Above-mentioned each Chinese medicinal components total amount is absolutely.

From technical scheme traditional Chinese medical science pathological analysis of the present invention:

How angry by being worried mastopathy is, irritability is lost in catharsis or Chong and Ren channel disorder and caused meridians to be obstructed, the ying-qi discord, and qi depression to blood stasis, phlegm-damp condense and form.The present invention just with depressed liver-energy dispersing and QI regulating, open breast pleasant to be principle, to reach the purpose of treatment by the activating blood circulation to dissipate blood stasis and dredge the collateral eliminating stagnation.

From technical solution of the present invention traditional Chinese medical science pharmacology analysis-by-synthesis

According to traditional Chinese medical science pathological analysis, through various Chinese medicinal components screenings are analyzed, trial-production and clinical and experimental study, proposed to select for use, it is to use together for " monarch " four Chinese medicine with Radix Bupleuri, Radix Scutellariae, Rhizoma Cyperi, Cortex Magnoliae Officinalis that ten Six-element Chinese medicines such as Radix Bupleuri process pharmacology analysis, take the lead in opening the road of the thoracic obstruction, the irritability bar is reached, chest breadth gas is smooth.With Pericarpium Citri Reticulatae, the Rhizoma Pinelliae, Spica Prunellae, rhizoma sparganic, Rhizoma Curcumae, Myrrha, the dissipating phlegm and resolving masses of Flos Carthami Six-element medicine, collateral dredging is invigorated blood circulation " minister ", and promoting tissue regeneration by removing blood stasis, breast knot are from loosing, and " assistant " assists to relieve the pain to regulate the flow of vital energy with Rhizoma Corydalis, Radix Curcumae, Pericarpium Citri Reticulatae Viride, the Radix Paeoniae Alba.SHENGCAO is " making " person, draws Chinese medicine and returns the twelve regular channels to go into internal organs, reaches therapeutic purposes, thoroughly removes the cyclomastopathy misery.

More than all medicines " monarch " synergism, supplement and complement each other common conditioning.The gas of liver spleen, blood circulation promoting and blood stasis dispelling, activating collaterals and eliminating stagnation has tangible permanent curing action to mastopathy, and no matter which kind of dosage form this medicine is, all have no side effect, but i.e. oral administration external application again, Chinese medicine, it is main effecting a permanent cure.

The present invention be one group through many decades success of the test and research and development through proved recipe, treatment mammary gland class, cyclomastopathy, mammary gland tumor and just mid-term, the mammary gland caking all had certain curative effect, cure rate reaches more than 95%, and gynaecopathia is also had the effect of suitable effect, and has no side effect.

Embodiment

A kind of mammary gland eliminating stagnation Chinese medicine, the percentage by weight of each Chinese medicinal components optimum content is:

Radix Bupleuri 10% Radix Scutellariae 10% Rhizoma Cyperi 15% Cortex Magnoliae Officinalis 15%

Pericarpium Citri Reticulatae 10% Rhizoma Pinelliae 10% Spica Prunellae 20% rhizoma sparganic 15%

Rhizoma Curcumae 15% Myrrha 10% Radix Curcumae 10% Rhizoma Corydalis 10%

SHENGCAO 6% Flos Carthami 6% Pericarpium Citri Reticulatae Viride 10% Radix Paeoniae Alba 10%

Also can comprise excipient, filler, flavoring agent.

The dosage form of product can be a capsule, loose powder agent, sheet granule, cream pill, liquid oral liquid or external application liniment.

Claims (2)

1. a Chinese medicine for the treatment of mastopathy is characterized in that being processed into by following raw materials by weight percent.

Radix Bupleuri 1-25% Radix Scutellariae 1-25% Rhizoma Cyperi 1-50% Cortex Magnoliae Officinalis 1-50%

Pericarpium Citri Reticulatae 1-25% Rhizoma Pinelliae 1-25% Spica Prunellae 1-60% rhizoma sparganic 1-90%

Rhizoma Curcumae 1-50% Myrrha 1-25% Radix Curcumae 1-25% Rhizoma Corydalis 1-25%

SHENGCAO 1-20% Flos Carthami 1-20% Pericarpium Citri Reticulatae Viride 1-25% Radix Paeoniae Alba 1-25%.

2. the Chinese medicine of treatment mastopathy according to claim 1 is characterized in that by the percentage by weight of following traditional Chinese medicines component optimum content being:

Radix Bupleuri 10% Radix Scutellariae 10% Rhizoma Cyperi 15% Cortex Magnoliae Officinalis 15%

Pericarpium Citri Reticulatae 10% Rhizoma Pinelliae 10% Spica Prunellae 20% rhizoma sparganic 15%

Rhizoma Curcumae 15% Myrrha 10% Radix Curcumae 10% Rhizoma Corydalis 10%

SHENGCAO 6% Flos Carthami 6% Pericarpium Citri Reticulatae Viride 10% Radix Paeoniae Alba 10%.